-
Loading metrics
Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency
- Xavier Calvet,
- Miquel Àngel Ruíz,
- Angelina Dosal,
- Laura Moreno,
- Maria López,
- Ariadna Figuerola,
- David Suarez,
- Mireia Miquel,
- Albert Villoria,
- Emili Gené
x
- Published: September 21, 2012
- https://doi.org/10.1371/journal.pone.0045604